Identifies therapeutic alternatives during drug shortages with clinical equivalence assessment, conservation strategies, and communication protocols.

Why This Skill Exists

Drug shortages are a persistent and growing threat to patient safety in the United States, with over 300 active shortages reported annually by the ASHP Drug Shortage Resource Center and the FDA Drug Shortage Database. Shortages affect critical medications including injectable opioids, chemotherapy agents, IV fluids, antibiotics, and electrolyte replacements. ASHP surveys indicate that 99% of hospital pharmacists have managed at least one drug shortage, and 47% report that shortages have contributed to medication errors.

The causes are multifactorial: manufacturing quality failures (FDA 483 citations), raw material supply chain disruptions, just-in-time inventory practices, limited manufacturing redundancy, and economic disinvestment in low-margin generic injectables. The Drug Shortage Staffing Assessment (ASHP 2019) found that hospital pharmacists spend an average of 8.6 hours per week managing drug shortages. ASHP Guidelines on Managing Drug Product Shortages provide the standard framework: identify the shortage, assess clinical impact, develop therapeutic alternatives, implement conservation strategies, communicate to stakeholders, and monitor outcomes. Failure to manage shortages systematically leads to treatment delays, suboptimal substitution, medication errors, and patient harm.

Severity Level	Definition	Response Timeframe
Critical	No therapeutic alternative available; life-threatening impact	Immediate (within hours)
High	Alternatives exist but require significant clinical adjustment	Within 24-48 hours
Moderate	Alternatives are clinically equivalent and available	Within 1 week
Low	Shortage affects convenience but not clinical outcomes	Standard process

Evaluation Criteria	Alternative A	Alternative B	Alternative C
Drug name and dose
Route and formulation
Clinical equivalence evidence
Pharmacokinetic differences
Safety profile comparison
Current formulary status
Supply chain stability
Cost comparison
Monitoring requirement changes
Required dose conversion

Shortage Drug	Typical Alternatives	Key Considerations
Normal saline IV bags	Lactated Ringer's, PlasmaLyte	Avoid LR with citrate-sensitive products
IV push opioids (morphine, hydromorphone)	Oral opioids (if GI functional), PCA, fentanyl IV	Equianalgesic conversion required
Norepinephrine	Phenylephrine, vasopressin, epinephrine	Different receptor profiles; clinical impact
Sodium bicarbonate injection	Tromethamine (THAM) for specific indications	Not equivalent for all indications
Ondansetron IV	Granisetron IV, oral ondansetron, promethazine	Avoid promethazine IV push
Dextrose 50%	Dextrose 25% (double volume), glucagon IM	Different volume and administration

Audience	Communication Method	Content	Timing
Pharmacists	Pharmacy department memo + staff meeting	Shortage details, alternatives, dispensing changes	Day 1
Prescribers/medical staff	EHR banner, email, medical director notification	Shortage notice, approved alternatives, order changes	Day 1-2
Nursing	Nursing communication, ADC alerts	New product preparation/administration, look-alike warnings	Day 1-2
P&T Committee	Emergency therapeutic interchange notification	Alternative protocols for committee ratification	Per urgency
Administration	Impact summary for pharmacy leadership	Financial impact, supply timeline, risk assessment	Day 2-3
Patients (if applicable)	Prescriber-led conversation, pharmacy counseling	Why medication is changing, expected equivalence	At transition

Managing Drug Shortages

Managing Drug Shortages

Why This Skill Exists

Checkpoint A: Pre-Draft Intake (Mandatory)

Documents to Request

Step 1: Verify and Classify the Shortage

Step 2: Develop Therapeutic Alternatives

Step 3: Implement Conservation Strategies

Step 4: Communication and Documentation

Step 5: Monitor and Resolve

Checkpoint B: Post-Draft Alignment (Mandatory)

Quality Audit

Guidelines

Things Mac

Trello

Production Scheduling

Jira Integration

Production Scheduling

Cost Aware Llm Pipeline